Form 4: Cerus Corp Executive Laurence M. Corash Reports Stock Sales

Laurence M. Corash, Chief Scientific Officer of Cerus Corporation, reported the sale of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Laurence M. Corash, Chief Scientific Officer of Cerus Corporation, filed a Form 4 detailing changes in beneficial ownership.
• On March 12, 2024, 16,666 restricted stock units vested and were converted into common stock.
• Corash sold 14,067 shares on March 13, 2024, at an average price of $2.057 per share.
• He also sold 14,360 shares on March 14, 2024, at an average price of $1.9744 per share.
• These sales were executed to cover statutory tax withholding obligations and brokerage fees related to the vesting of restricted stock units, according to a pre-arranged Rule 10b5-1 trading plan.
• Following these transactions, Corash directly owns 2,339,740 shares of Cerus common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document simply reports stock sales by an executive under a pre-arranged plan for tax purposes. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. The use of Rule 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely minimal given the relatively small volume of shares sold compared to the total outstanding shares.

Key Dates